Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
Molecules (Basel, Switzerland)
|
February 15, 2022
2-Hydroxyestradiol Overcomes Mesenchymal Stem Cells-Mediated Platinum Chemoresistance in Ovarian Cancer Cells in an ERK-Independent Fashion
Hazem Khamaisi, Hatem Mahmoud, Jamal Mahajna
International Journal of Molecular Sciences
|
December 10, 2021
Natural Products Targeting Cancer Stem Cells for Augmenting Cancer Therapeutics
Ari Meerson, Soliman Khatib, Jamal Mahajna
Anticancer Research
|
May 28, 2011
NF-κB activation by peroxynitrite through IκBα-dependent phosphorylation versus nitration in colon cancer cells
Einat Gochman, Jamal Mahajna, Abraham Z Reznick
International Journal of Oncology
|
May 24, 2008
Substances from the medicinal mushroom Daedalea gibbosa inhibit kinase activity of native and T315I mutated Bcr-Abl
Majed Yassin, Solomon P Wasser, Jamal Mahajna
Integrative Cancer Therapies
|
December 15, 2010
The culinary-medicinal mushroom Coprinus comatus as a natural antiandrogenic modulator
Nesly Dotan, Solomon P Wasser, Jamal Mahajna
Nutrition and Cancer
|
October 11, 2011
Inhibition of the androgen receptor activity by Coprinus comatus substances
Nesly Dotan, Solomon P Wasser, Jamal Mahajna
International Journal of Oncology
|
September 6, 2007
Androgen receptor-dependent and -independent mechanisms mediate Ganoderma lucidum activities in LNCaP prostate cancer cells
Ben-Zion Zaidman, Solomon P Wasser, Eviatar Nevo, et al.
Molecular Biology Reports
|
April 14, 2007
Coprinus comatus and Ganoderma lucidum interfere with androgen receptor function in LNCaP prostate cancer cells
Ben-Zion Zaidman, Solomon P Wasser, Eviatar Nevo, et al.
Applied Microbiology and Biotechnology
|
February 24, 2005
Medicinal mushroom modulators of molecular targets as cancer therapeutics
Ben-Zion Zaidman, Majed Yassin, Jamal Mahajna, et al.
Hematology, Transfusion and Cell Therapy
|
January 11, 2026
Hypoxic conditions confer chemoresistance to crizotinib but not to imatinib in chronic myeloid leukemia cells
Lena Avinery, Danielle Regev, Hazem Khamaisi, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
Molecules (Basel, Switzerland)
|
February 15, 2022
2-Hydroxyestradiol Overcomes Mesenchymal Stem Cells-Mediated Platinum Chemoresistance in Ovarian Cancer Cells in an ERK-Independent Fashion
Hazem Khamaisi, Hatem Mahmoud, Jamal Mahajna
International Journal of Molecular Sciences
|
December 10, 2021
Natural Products Targeting Cancer Stem Cells for Augmenting Cancer Therapeutics
Ari Meerson, Soliman Khatib, Jamal Mahajna
Anticancer Research
|
May 28, 2011
NF-κB activation by peroxynitrite through IκBα-dependent phosphorylation versus nitration in colon cancer cells
Einat Gochman, Jamal Mahajna, Abraham Z Reznick
International Journal of Oncology
|
May 24, 2008
Substances from the medicinal mushroom Daedalea gibbosa inhibit kinase activity of native and T315I mutated Bcr-Abl
Majed Yassin, Solomon P Wasser, Jamal Mahajna
Integrative Cancer Therapies
|
December 15, 2010
The culinary-medicinal mushroom Coprinus comatus as a natural antiandrogenic modulator
Nesly Dotan, Solomon P Wasser, Jamal Mahajna
Nutrition and Cancer
|
October 11, 2011
Inhibition of the androgen receptor activity by Coprinus comatus substances
Nesly Dotan, Solomon P Wasser, Jamal Mahajna
International Journal of Oncology
|
September 6, 2007
Androgen receptor-dependent and -independent mechanisms mediate Ganoderma lucidum activities in LNCaP prostate cancer cells
Ben-Zion Zaidman, Solomon P Wasser, Eviatar Nevo, et al.
Molecular Biology Reports
|
April 14, 2007
Coprinus comatus and Ganoderma lucidum interfere with androgen receptor function in LNCaP prostate cancer cells
Ben-Zion Zaidman, Solomon P Wasser, Eviatar Nevo, et al.
Applied Microbiology and Biotechnology
|
February 24, 2005
Medicinal mushroom modulators of molecular targets as cancer therapeutics
Ben-Zion Zaidman, Majed Yassin, Jamal Mahajna, et al.
Hematology, Transfusion and Cell Therapy
|
January 11, 2026
Hypoxic conditions confer chemoresistance to crizotinib but not to imatinib in chronic myeloid leukemia cells
Lena Avinery, Danielle Regev, Hazem Khamaisi, et al.
Page
of 4